These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28393315)

  • 1. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
    Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
    Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying differentially expressed genes and screening small molecule drugs for lapatinib-resistance of breast cancer by a bioinformatics strategy.
    Zhuo WL; Zhang L; Xie QC; Zhu B; Chen ZT
    Asian Pac J Cancer Prev; 2014; 15(24):10847-53. PubMed ID: 25605188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel therapeutic target genes in acquired lapatinib-resistant breast cancer by integrative meta-analysis.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Choi JD; Kwon K; Jang CS; Ro YT; Noh YH; Kim SY
    Tumour Biol; 2016 Feb; 37(2):2285-97. PubMed ID: 26361955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance.
    Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY
    Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer.
    Bao S; Chen Y; Yang F; Sun C; Yang M; Li W; Huang X; Li J; Wu H; Yin Y
    Front Pharmacol; 2020; 11():577150. PubMed ID: 33013420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-platform meta-analysis of multiple gene expression profiles identifies novel expression signatures in acquired anthracycline-resistant breast cancer.
    Lee YS; Ryu SW; Bae SJ; Park TH; Kwon K; Noh YH; Kim SY
    Oncol Rep; 2015 Apr; 33(4):1985-93. PubMed ID: 25695524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering novel cancer bio-markers in acquired lapatinib resistance using Bayesian methods.
    Azad AKM; Alyami SA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33857297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines.
    O'Neill F; Madden SF; Aherne ST; Clynes M; Crown J; Doolan P; O'Connor R
    Mol Cancer; 2012 Jun; 11():41. PubMed ID: 22709873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells.
    Ma C; Zuo W; Wang X; Wei L; Guo Q; Song X
    Oncol Rep; 2013 Feb; 29(2):812-8. PubMed ID: 23229346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    Takeda T; Yamamoto H; Kanzaki H; Suzawa K; Yoshioka T; Tomida S; Cui X; Murali R; Namba K; Sato H; Torigoe H; Watanabe M; Shien K; Soh J; Asano H; Tsukuda K; Kitamura Y; Miyoshi S; Sendo T; Toyooka S
    PLoS One; 2017; 12(2):e0171356. PubMed ID: 28158234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinib.
    Christenson JL; Denny EC; Kane SE
    Oncotarget; 2015 Oct; 6(32):33134-45. PubMed ID: 26430732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
    Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis.
    Wei J; Han R; Su X; Chen Y; Shi J; Cui X; Zhang H; Gong Y; Chu X; Chen J
    Oncol Lett; 2019 Jul; 18(1):197-206. PubMed ID: 31289489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
    Zheng T; Wang A; Hu D; Wang Y
    Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.